{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:10:23Z","timestamp":1697069423057},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.etp.2010.04.001","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T14:04:25Z","timestamp":1274969065000},"page":"511-517","source":"Crossref","is-referenced-by-count":5,"title":["Differential immunotoxicity of histone deacetylase inhibitors on malignant and na\u00efve hepatocytes"],"prefix":"10.1016","volume":"63","author":[{"given":"Markus","family":"Weiller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Weiland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"D\u00fcnstl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"K\u00fcnstle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.etp.2010.04.001_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumour-necrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.etp.2010.04.001_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0955-0674(99)80034-9","article-title":"Apoptosis control by death and decoy receptors","volume":"11","author":"Ashkenazi","year":"1999","journal-title":"Curr Opin Cell Biol"},{"issue":"5288","key":"10.1016\/j.etp.2010.04.001_bib3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","article-title":"An essential role for NF-kappaB in preventing TNF-alpha-induced cell death","volume":"274","author":"Beg","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.etp.2010.04.001_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/clinchem\/24.1.58","article-title":"Optimization of methods for aspartate aminotransferase and alanine aminotransferase","volume":"2","author":"Bergmeyer","year":"1978","journal-title":"Clin Chem"},{"key":"10.1016\/j.etp.2010.04.001_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.42.083101.143836","article-title":"Cellular mechanisms for the repression of apoptosis","volume":"42","author":"Bortner","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.etp.2010.04.001_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","article-title":"Sodium butyrate inhibits histone deacetylation in cultured cells","volume":"14","author":"Candido","year":"1978","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.etp.2010.04.001_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.yexcr.2004.04.038","article-title":"Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors\u2019 signalling and requires P21(waf1)","volume":"298","author":"Chopin","year":"2004","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.etp.2010.04.001_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bjp.0704456","article-title":"Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells","volume":"135","author":"Chopin","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.etp.2010.04.001_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.181.1.393","article-title":"Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome","volume":"181","author":"Chu","year":"2002","journal-title":"J Exp Med"},{"issue":"13","key":"10.1016\/j.etp.2010.04.001_bib9","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/MCB.25.13.5429-5444.2005","article-title":"Blockade of histone deacetylase inhibitor-induced RelA\/p65 acetylation and NF-\u03baB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation","volume":"25","author":"Dai","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.etp.2010.04.001_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","article-title":"Clinical development of histone deacetylase inhibitors as anticancer agents","volume":"45","author":"Drummond","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"8","key":"10.1016\/j.etp.2010.04.001_bib11","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1349-7006.2008.00868.x","article-title":"Differential responsiveness of human hepatoma cells versus normal hepatocytes to TRAIL in combination with either histone deacetylase inhibitors or conventional cytostatics","volume":"99","author":"Dzieran","year":"2008","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.etp.2010.04.001_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1023\/B:APPT.0000038036.31271.50","article-title":"Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors","volume":"9","author":"Facchetti","year":"2004","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.etp.2010.04.001_bib13","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"6749","key":"10.1016\/j.etp.2010.04.001_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.etp.2010.04.001_bib15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.182.5.1223","article-title":"Involvement of the CD95 (APO-1\/Fas) receptor and ligand in liver damage","volume":"182","author":"Galle","year":"1995","journal-title":"J Exp Med"},{"issue":"24","key":"10.1016\/j.etp.2010.04.001_bib16","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Goettlicher","year":"2001","journal-title":"Embo J"},{"issue":"2","key":"10.1016\/j.etp.2010.04.001_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1067\/msy.2001.115897","article-title":"Butyrate sensitises human colon cancer cells to TRAIL-mediated apoptosis","volume":"130","author":"Hernandez","year":"2001","journal-title":"Surgery"},{"issue":"6638","key":"10.1016\/j.etp.2010.04.001_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.etp.2010.04.001_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2001","journal-title":"Nat Rev Drug Discovery"},{"issue":"8","key":"10.1016\/j.etp.2010.04.001_bib20","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.161.8.3936","article-title":"FLIP prevents apoptosis induced by death receptors but not by perforin\/granzyme B, chemotherapeutic drugs, and gamma irradiation","volume":"161","author":"Kataoka","year":"1998","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.etp.2010.04.001_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/106002809202600311","article-title":"The effects of impaired liver function on the elimination of antineoplastic agents","volume":"26","author":"Koren","year":"1992","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.etp.2010.04.001_bib22","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4049\/jimmunol.153.4.1778","article-title":"Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest","volume":"153","author":"Leist","year":"1994","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.etp.2010.04.001_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2893.1997.00053.x","article-title":"In situ investigation of Fas\/FasL expression in chronic hepatitis B infection and related liver diseases","volume":"4","author":"Luo","year":"1997","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.etp.2010.04.001_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00062752-200207000-00010","article-title":"Histone deacetylases as therapeutic targets in hematologic malignancies","volume":"9","author":"Melnick","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.etp.2010.04.001_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.2536759100","article-title":"Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications","volume":"101","author":"Mitsiades","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.etp.2010.04.001_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.etp.2010.04.001_bib28","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1073\/pnas.0500369102","article-title":"Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors","volume":"102","author":"Peart","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.etp.2010.04.001_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.21054","article-title":"HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL","volume":"43","author":"Pathil","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.etp.2010.04.001_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.cdd.4401186","article-title":"The CD95(APO-1\/Fas) DISC and beyond","volume":"10","author":"Peter","year":"2003","journal-title":"Cell Death Differ"},{"issue":"5","key":"10.1016\/j.etp.2010.04.001_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/13543784.16.5.659","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"16","author":"Rasheed","year":"2007","journal-title":"Expert Opin Invest Drugs"},{"issue":"1","key":"10.1016\/j.etp.2010.04.001_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4161\/cbt.190","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"2","author":"Rosato","year":"2003","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"10.1016\/j.etp.2010.04.001_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.surg.2008.03.034","article-title":"Acetylation: a novel method for modulation of the immune response following trauma\/hemorrhage and inflammatory second hit in animals and humans","volume":"144","author":"Sailhamer","year":"2008","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.etp.2010.04.001_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0014-4827(73)90357-1","article-title":"Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion","volume":"82","author":"Seglen","year":"1973","journal-title":"Exp Cell Res"},{"issue":"42","key":"10.1016\/j.etp.2010.04.001_bib36","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0404603101","article-title":"Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor","volume":"101","author":"Vannini","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6638","key":"10.1016\/j.etp.2010.04.001_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/40516","article-title":"Apoptosis. Placing death under control","volume":"388","author":"Wallach","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.etp.2010.04.001_bib38","first-page":"681","article-title":"Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents","volume":"6","author":"Witzig","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.etp.2010.04.001_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1074-7613(00)80214-9","article-title":"Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development","volume":"12","author":"Yeh","year":"2000","journal-title":"Immunity"}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299310000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299310000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T09:25:50Z","timestamp":1685611550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940299310000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0940299310000485"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2010.04.001","relation":{},"ISSN":["0940-2993"],"issn-type":[{"value":"0940-2993","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}